SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: paul goldstein who wrote (4003)12/6/1998 5:08:00 PM
From: blackmerlin   of 4342
 
Paul:

I agree with your post and went for AMBI at 1.1875/share. I looked at PRLN and AMBI extensively and saw all the problems you mentioned for PRLN. AMBI may be a good buying opportunity right now. The daily trading volume on AMBI is approx. 130,000. Less chance of manipulation by the mice. Also AMBI should experience price gains as retail distribution of the company's products increases due to American Home Product's involvement:

From AMBI's 11/98 form 10-Q:

"On October 8, l998, the Company commenced a strategic alliance with AHP for retail distribution of the Company's proprietary nutrition
products. As part of the alliance, AHP's Whitehall-Robins Healthcare
Division was granted an exclusive license to sell the Company's
Cardia(Registered) Salt in retail markets in the United States and
received a first negotiation option for exclusive rights and licenses
for additional nutrition products for retail distribution in the United States".

Regards,

Jake Blackmerlin







Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext